Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ABBV-1480 |
| Trade Name | |
| Synonyms | ABBV1480|ABBV 1480|RC148|RC-148|RC 148 |
| Drug Descriptions |
ABBV-1480 is bispecific antibody targeting PDCD1 (PD-1) and VEGF, which potentially induces T-cell activation and inhibits growth and migration of tumor cells (Cancer Res (2024) 84 (6_Supplement): 2734). |
| DrugClasses | PD-L1/PD-1 antibody 139 VEGF Antibody 18 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ABBV-1480 | ABBV-1480 | 0 | 0 |
| ABBV-1480 + Carboplatin + Nab-paclitaxel | ABBV-1480 Carboplatin Nab-paclitaxel | 0 | 0 |
| ABBV-1480 + Carboplatin + Paclitaxel | ABBV-1480 Carboplatin Paclitaxel | 0 | 0 |